|
Volumn 28, Issue 2, 2001, Pages 321-334
|
Oral drug therapy for erectile dysfunction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
APOMORPHINE;
ARGININE;
CYCLIC AMP;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENDOTHELIN RECEPTOR ANTAGONIST;
INTERMEDIN;
NITRIC OXIDE;
PHOSPHODIESTERASE INHIBITOR;
POTASSIUM CHANNEL STIMULATING AGENT;
SILDENAFIL;
TADALAFIL;
UNCLASSIFIED DRUG;
YOHIMBINE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DIARRHEA;
DRUG SAFETY;
DYSPEPSIA;
ERECTILE DYSFUNCTION;
HEADACHE;
HEART INFARCTION;
HUMAN;
NOSE CONGESTION;
PRIORITY JOURNAL;
REVIEW;
SOMNOLENCE;
TREATMENT INDICATION;
URINARY TRACT INFECTION;
VERTIGO;
VISUAL IMPAIRMENT;
|
EID: 0034992798
PISSN: 00940143
EISSN: None
Source Type: Journal
DOI: 10.1016/S0094-0143(05)70141-5 Document Type: Article |
Times cited : (99)
|
References (39)
|